P

PNEUMAGEN LIMITED

8 employees

Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Wellness

Date founded

2016

Funding rounds raised

Total raised

$10M

from 2 investors over 2 rounds

P

PNEUMAGEN LIMITED raised $10M on June 1, 2023

Investors: Scottish Enterprise

P

PNEUMAGEN LIMITED raised $5.2M on January 19, 2022

Investors: Scottish Enterprise

FAQ